Clinical Trials Logo

Skin Infection clinical trials

View clinical trials related to Skin Infection.

Filter by:

NCT ID: NCT04239521 Completed - Asthma Clinical Trials

The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata

Start date: October 1, 2020
Phase:
Study type: Observational

This study series consists of four related studies and aims to explore and describe many important elements of alopecia areata over three key areas: (1) the current epidemiology of alopecia areata, (2) the prevalence and incidence of psychiatric co-morbidities in people with alopecia areata, (3) the prevalence and incidence of autoimmune and atopic conditions in people with alopecia areata, and (4) the incidence of common infections in people with alopecia areata.

NCT ID: NCT03929224 Completed - Skin Infection Clinical Trials

The Use of Medical Grade Honey in the Prevention of Bone Anchored Hearing Aid Associated Skin Breakdown

Start date: October 25, 2018
Phase: Phase 4
Study type: Interventional

Postoperative medicinal grade honey in post-operative care may prevent bone anchored hearing aid associated skin breakdown better than standard care of bacitracin ointment alone in adult patients.

NCT ID: NCT03637400 Recruiting - Clinical trials for Methicillin-resistant Staphylococcus Aureus

Short and Long Term Outcomes of Doxycycline Versus Trimethoprim-Sulfamethoxazole for Skin and Soft Tissue Infections Treatment

TODOS
Start date: November 26, 2018
Phase: Phase 2
Study type: Interventional

The purpose of this study is to compare how well two different antibiotics, doxycycline (DOXY) and trimethoprim/sulfamethoxazole (TMP/SMX), work at curing uncomplicated skin and soft tissue infection (uSSTI) such as 1.Boils (pus in the skin, also known as abscesses and furuncles) or 2. Infections that appear only on the skin surface (called cellulitis and erysipelas) that have pus.

NCT ID: NCT03372941 Terminated - Skin Infection Clinical Trials

Hospital Avoidance Strategies for ABSSSI

Start date: March 4, 2019
Phase: Phase 4
Study type: Interventional

More than 40% of patients presenting with acute bacterial skin and skin structure infection (ABSSSI) to the Barnes-Jewish Hospital (BJH) emergency department (ED) are admitted for intravenous antibiotics. There is growing evidence to suggest that many hospital admissions for uncomplicated ABSSSI due to Gram-positive bacteria could be avoided with an alternative treatment strategy employing newer long-acting antibiotics. Coupled with close outpatient follow-up, such an alternative hospital avoidance strategy has the potential to improve quality and value of care for patients with uncomplicated ABSSSI and optimize use of limited inpatient healthcare resources.

NCT ID: NCT03131843 Recruiting - Skin Infection Clinical Trials

Effectiveness of Alcohol Swabs for Preventing Infections During Vaccination

Start date: May 1, 2017
Phase: Phase 3
Study type: Interventional

Alcohol is used to disinfect the skin prior to injections in order to prevent infections caused by bacteria on the skin being injected within tissue. At present, however, clinical trials do not demonstrate a clinical impact of using or not using alcohol swabs on infections and infection symptoms calling into question the practice of using it prior to all injections. These studies are methodologically flawed, and do not specifically examine vaccine injections. The present study is being undertaken to provide some preliminary data for the risk of infection and infection symptoms when alcohol swabs are not used to perform vaccine injections.

NCT ID: NCT02512614 Completed - Fever Clinical Trials

Evaluation of Novel Antimicrobial Hand Towels

Start date: March 2012
Phase: Phase 2/Phase 3
Study type: Interventional

In March 2012, the investigators initiated a prospective, cluster-randomized, controlled field trial in Kisumu County, located in an area in western Kenya which has the highest under-five mortality rate in Kenya with 149 childhood deaths per 1,000 live births 9. The study was designed to evaluate the effectiveness of an antimicrobial hand towel (hereafter referred to as towel) in preventing diarrheal diseases, acute respiratory infections, self-reported fever, and skin infections in children <2 years old.

NCT ID: NCT02052388 Completed - Bacterial Infection Clinical Trials

Efficacy and Safety Study of Brilacidin to Treat Serious Skin Infections

Start date: February 2014
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine the safety and efficacy of three different dosing regimens of brilacidin compared to daptomycin for the treatment of serious skin infections. This study will aid in selecting the appropriate dose of brilacidin for later stage studies.

NCT ID: NCT01593761 Completed - Skin Infection Clinical Trials

Phase 2a Study of CG400549 for the Treatment of cABSSSI Caused by Methicillin-resistant Staphylococcus Aureus

CG400549
Start date: June 2012
Phase: Phase 2
Study type: Interventional

Primary Objective: To make a preliminary assessment of the efficacy of CG400549 (960 mg daily) in subjects with cABSSSI (major cutaneous abscesses) due to MRSA. Secondary Objective(s): - To assess the pharmacokinetics of CG400549 (960 mg daily) in subjects with cABSSSI due to MRSA - To explore the in vitro susceptibility of cABSSSI-related bacteria to CG400549. - To assess the safety of multiple doses of CG400459

NCT ID: NCT00619710 Completed - Cellulitis Clinical Trials

Complicated Skin and Skin Structure Infections

Start date: February 2001
Phase: Phase 3
Study type: Interventional

The purpose of this study is to demonstrate the non-inferiority of meropenem (Merrem) and imipenem in hospitalised subjects with complicated skin and skin structure infections.